Woolsey Pharmaceuticals, Inc.

Woolsey Pharmaceuticals is focused on the treatment of rare, neurodegenerative diseases. Many neurodegenerative diseases – including Alzheimer’s, vascular dementia, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, Huntington’s disease, multiple sclerosis, progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) – occur as a result of the progressive death of neurons in different regions of the nervous system. Woolsey Pharmaceuticals focuses on neurodegenerative diseases. Woolsey Pharmaceuticals is focused on the treatment of rare, neurodegenerative diseases. Woolsey Pharmaceuticals does not discover new drugs. We are an indications discovery company. We discover new ways to use existing drugs for other diseases and conditions for which patients in need have no therapeutic solutions.